Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807846
DOI: 10.1055/s-0045-1807846
HEAD AND NECK TUMORS
2054
POSTER PRESENTATION
Efficacy and safety of flunarizine in preventing ototoxicity associated with cisplatin-based concurrent chemoradiotherapy in head and neck cancer patients: a phase II single-arm study
Publication History
Article published online:
06 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Katia Regina Marchetti, Marcelo Malandrino de Albuquerque Felizola, Jéssica Kipper Martinez, Marília Polo Mingueti e Silva, Fernanda Frozoni Antonacio, Guilherme Fialho de Freitas, Ricardo Dahmer Tiecher, Francesco Sansone, Jessica Monteiro Vasconcellos, Paulo Siqueira Amaral, Erika Andrade Rocha, Carina Müller Corsi, Gabriel Faria Najas, Gustavo Nader Marta, Marcelle Kubo Sakamoto, Gilberto de Castro Junior. Efficacy and safety of flunarizine in preventing ototoxicity associated with cisplatin-based concurrent chemoradiotherapy in head and neck cancer patients: a phase II single-arm study. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807846
Katia Regina Marchetti, Marcelo Malandrino de Albuquerque Felizola, Jéssica Kipper Martinez, Marília Polo Mingueti e Silva, Fernanda Frozoni Antonacio, Guilherme Fialho de Freitas, Ricardo Dahmer Tiecher, Francesco Sansone, Jessica Monteiro Vasconcellos, Paulo Siqueira Amaral, Erika Andrade Rocha, Carina Müller Corsi, Gabriel Faria Najas, Gustavo Nader Marta, Marcelle Kubo Sakamoto, Gilberto de Castro Junior. Efficacy and safety of flunarizine in preventing ototoxicity associated with cisplatin-based concurrent chemoradiotherapy in head and neck cancer patients: a phase II single-arm study. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807846